参考文献/References:
[1]贺嘉,陈雄彪,张澍,等.冷冻球囊消融治疗心房颤动一年随访结果分析[J].中华心律失常学杂志,2016,20(4):332-335. [2]韩聪,胡建宏,胡姗,等.长链非编码RNA研究进展[J].生物技术通讯,2018,29(1):123-130. [3]Da CM,Gong CY,Nan W,et al.The role of long non-coding RNA MIAT in cancers[J].Biomed Pharmacother,2020(129):110359. [4]姜亦瑶,王凯,施超.心肌纤维化引发心房颤动的研究进展[J].医学信息,2018,31(12):28-30. [5]于雪婧,邹彤,杨杰孚.心房颤动患者外周血淋巴细胞基因及长链非编码RNA表达谱的研究[J].中国循环杂志,2017,32(z1):22-23. [6]马如超,闫波.心肌梗死长链非编码RNA-相关转录本基因与心血管疾病研究进展[J].心肺血管病杂志,2018,37(10):942-943,951. [7]Qu X,Du Y,Shu Y,et al.MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium[J].Sci Rep,2017(7):42657. [8]Zhou J,Zhou Y,Wang CX.LncRNA-MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR-29a-3p[J].J Cell Biochem,2018,120(5):7265-7275. [9]Yao L,Zhou B,You L,et al.LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis[J].Mol Biol Rep,2020,47(4):2605-2617. [10]Hagiwara N.Inflammation and atrial fibrillation[J].Circ J,2010,74(2):246-247. [11]Liu Y,Shi Q,Ma Y,et al.The role of immune cells in atrial fibrillation[J].J Mol Cell Cardiol,2018(123):198-208. [12]Aguiar CM,Gawdat K,Legere S,et al.Fibrosis independent atrial fibrillation in older patients is driven by substrate leukocyte infiltration: diagnostic and prognostic implications to patients undergoing cardiac surgery[J].J Transl Med,2019,17(1):413. [13]陈金盛,江灿,郭军.不同BMI水平对新发房颤风险影响的Meta分析[J].中国循证心血管医学杂志,2017,9(3):265-268,272. [14]贾朝旭,蒋超,马长生,等.体重控制与超重及肥胖患者心房颤动射频消融术后复发的关系[J].中华心血管病杂志,2019(8):595-601. [15]Ling LH,Kistler PM,Ellims AH,et al.Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction[J].J Am Coll Cardiol,2012,60(23):2402-2408.
相似文献/References:
[1]姜亦瑶,王 凯,施 超.心肌纤维化引发心房颤动的研究进展[J].医学信息,2018,31(12):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
JIANG Yi-yao,WANG Kai,SHI Chao.Research Progress of Atrial Fibrillation Caused by Myocardial Fibrosis[J].Medical Information,2018,31(04):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
[2]张定欣,林先和.经食道三维超声在房颤二尖瓣结构变化对其
返流程度影响中的应用[J].医学信息,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
ZHANG Ding-xin,LIN Xian-he.Application of Transesophageal Three-dimensional Ultrasound in the Influence of Mitral Valve Structure Changes on the Degree of Reflux in Atrial Fibrillation[J].Medical Information,2018,31(04):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
[3]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对
糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Medical Information,2018,31(04):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[4]陶春艳.柔性护理在胺碘酮治疗心房颤动护理中的应用研究[J].医学信息,2018,31(24):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
TAO Chun-yan.Application of Flexible Nursing in the Treatment of Atrial Fibrillation with Amiodarone[J].Medical Information,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
[5]古俊楠,张牧秋,王建强,等.可穿戴设备在心房颤动诊治中的应用[J].医学信息,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
GU Jun-nan,ZHANG Mu-qiu,WANG Jian-qiang,et al.Application of Wearable Devices in the Diagnosis and Treatment of Atrial Fibrillation[J].Medical Information,2019,32(04):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
[6]刘 瑜,王建强,古俊楠,等.房颤合并功能性二尖瓣返流研究[J].医学信息,2019,32(15):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
LIU Yu,WANG Jian-qiang,GU Jun-nan,et al.Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation[J].Medical Information,2019,32(04):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
[7]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Medical Information,2019,32(04):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[8]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with
Atrial Fibrillation and ACS[J].Medical Information,2019,32(04):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[9]马 利,李丽华.aVR导联法在心房颤动伴宽QRS波群心动过速鉴别诊断中的应用[J].医学信息,2022,35(19):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
MA Li,LI Li-hua.Application of aVR Lead Method in Differential Diagnosis of Atrial Fibrillation with Wide QRS Complex Tachycardia[J].Medical Information,2022,35(04):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
[10]陈启松,何海军,谷光敏,等.IL-6基因多态性与心房颤动相关性的Meta分析[J].医学信息,2020,33(23):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
CHEN Qi-song,HE Hai-jun,GU Guang-min,et al.Meta Analysis of the Correlation Between IL-6 Gene Polymorphism and Atrial Fibrillation[J].Medical Information,2020,33(04):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]